Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.

Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, Malhotra A, Shea SA.

Sleep. 2012 Oct 1;35(10):1395-402.

2.
3.

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia.

Luthringer R, Muzet M, Zisapel N, Staner L.

Int Clin Psychopharmacol. 2009 Sep;24(5):239-49. doi: 10.1097/YIC.0b013e32832e9b08.

PMID:
19584739
4.

The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).

Appleton RE, Jones AP, Gamble C, Williamson PR, Wiggs L, Montgomery P, Sutcliffe A, Barker C, Gringras P.

Health Technol Assess. 2012;16(40):i-239. doi: 10.3310/hta16400.

5.

Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.

Chang YS, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, Sun C, Lin YT, Wang LC, Yu HH, Yang YH, Chen CA, Wan KS, Chiang BL.

JAMA Pediatr. 2016 Jan;170(1):35-42. doi: 10.1001/jamapediatrics.2015.3092.

PMID:
26569624
6.
7.

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.

Lancet. 2009 Feb 7;373(9662):482-91. doi: 10.1016/S0140-6736(08)61812-7. Epub 2008 Dec 4. Erratum in: Lancet. 2009 Apr 11;373(9671):1252.

PMID:
19054552
8.

Melatonin improves sleep quality of patients with chronic schizophrenia.

Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, Zisapel N.

J Clin Psychiatry. 2000 May;61(5):373-7.

PMID:
10847313
9.

Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.

Braam W, Didden R, Smits M, Curfs L.

J Intellect Disabil Res. 2008 Mar;52(Pt 3):256-64. doi: 10.1111/j.1365-2788.2007.01016.x.

PMID:
18261024
10.

Pharmacotherapies for sleep disturbances in dementia.

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2016 Nov 16;11:CD009178. Review.

PMID:
27851868
11.

Improvement of sleep quality in elderly people by controlled-release melatonin.

Garfinkel D, Laudon M, Nof D, Zisapel N.

Lancet. 1995 Aug 26;346(8974):541-4.

PMID:
7658780
13.

A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study..

Sleep. 2003 Nov 1;26(7):893-901.

14.

Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.

Randall S, Roehrs TA, Roth T.

Sleep. 2012 Nov 1;35(11):1551-7. doi: 10.5665/sleep.2208.

15.

Melatonin secretion related to side-effects of beta-blockers from the central nervous system.

Brismar K, Hylander B, Eliasson K, Rössner S, Wetterberg L.

Acta Med Scand. 1988;223(6):525-30.

PMID:
3291558
16.

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T.

Sleep. 2011 Oct 1;34(10):1433-42. doi: 10.5665/SLEEP.1294.

17.

The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.

Zemlan FP, Mulchahey JJ, Scharf MB, Mayleben DW, Rosenberg R, Lankford A.

J Clin Psychiatry. 2005 Mar;66(3):384-90.

PMID:
15766306
18.

Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.

Gooneratne NS, Gehrman P, Gurubhagavatula I, Al-Shehabi E, Marie E, Schwab R.

J Clin Sleep Med. 2010 Dec 15;6(6):572-80.

19.

Pharmacotherapies for sleep disturbances in Alzheimer's disease.

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2014 Mar 21;(3):CD009178. doi: 10.1002/14651858.CD009178.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Nov 16;11:CD009178.

PMID:
24659320
20.

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T.

Sleep. 2010 Nov;33(11):1553-61.

Supplemental Content

Support Center